The pandemic brought a windfall for private health tech startups and fueled a rush to the public markets. And in turn, leaders at some of the industry’s top companies saw their take-home pay skyrocket.
It’s difficult to draw broad conclusions about executive compensation in health tech — or how it stacks up to other sectors — because the industry itself is so loosely defined. It encompasses everything from telehealth and hybrid care companies to electronic health records vendors and businesses that gather and mine medical data for marketing. And while the health tech industry is rapidly growing, the presence on the public markets is relatively nascent. Newly public companies in 2020 and 2021 included insurance tech company Bright Health and prescription drug pricing giant GoodRx.
This article is exclusive to STAT+ subscribers
Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.
Already have an account? Log in
Already have an account? Log in
About the Author Reprints
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect